Share This Page
Patent: 6,004,297
✉ Email this page to a colleague
Summary for Patent: 6,004,297
| Title: | Injection syringe |
| Abstract: | An injection syringe comprises a housing (1), a piston rod (6) with a non-circular cross-section and an outer thread (7), a piston rod drive which includes a piston rod guide (85) mating with the cross-section of the piston rod (6), and a nut (4) which is not axially displaceable and which mates with the thread (7) of the piston rod (6) to form a self-locking thread connection. Rotation of a dose setting element (81) causes an injection button to be screwed out to project from the housing (1). When the injection button (88) is pushed axially, such axial movement is transformed, by way of the threaded coupling, into a rotation of one of the piston drive elements (85) relative to the other one (4). A unidirectional coupling between the nut member (4) and the piston rod guide (85) allows rotation in one direction by which the piston rod (6) is transported in a distal direction. The coupling has an initial reluctance to be overcome before rotation takes place, said reluctance being large enough to resist torques exerted during the dose setting. |
| Inventor(s): | Steenfeldt-Jensen; S.o slashed.ren (Hornb.ae butted.k, DK), Hansen; Steffen (Hiller.o slashed.d, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 09/238,849 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,004,297 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: | US Patent 6,004,297: What the Claims Actually Cover and Where the Landscape SqueezesUS Patent 6,004,297 (“6,004,297”) claims a dose-setting injection syringe architecture built around (1) a settable axial movement of an injection button that (2) mechanically converts into controlled distal transport of a cartridge piston via a thread-driven drive, with (3) a unidirectional coupling that prevents dose-setting rotation from driving the piston in the wrong direction unless an initial “reluctance” torque threshold is overcome. The key business value of the patent is the specific mechanical constraint stack: non-rotating axial guidance for the piston rod, self-locking drive threads for preventing backdriving, and a one-way coupling with a designed breakaway torque that blocks torque from dose setting until a threshold is exceeded. What follows is a claim-structure analysis, then a critical assessment of likely novelty/obviousness pressure points and the patent landscape logic (type of prior art to look for, and where enforcement leverage likely exists). 1) Claim-by-claim decomposition: what is protected vs what is merely structuralClaim 1: Core architecture and the one-way “breakaway torque” conceptClaim 1 requires an injection syringe with the following functional elements locked together: A. Dose reservoir and housing
B. Piston rod geometry and proximal distal drive
C. Dose setting mechanism using a dose setting rotation plus axial return translation
D. The discriminating limitation: unidirectional coupling between nut member and piston rod guide
Business meaning Claim 1 does not just claim a standard dose screw mechanism. It claims a mechanism that blocks dose-setting torque from inadvertently advancing the piston, then releases the coupling only when the axial-return-driven rotation produces torque above a threshold. That threshold language (“initial reluctance set large enough to resist a torque exerted on the coupling by the dose setting”) is the hook that can both (1) sharpen novelty and (2) narrow infringement if accused devices do not implement breakaway torque behavior in the described locations. Claim 2: A click coupling with moderate resistance in both rotation directions
Business meaning This adds a tactile/detent function. It is likely a high-frequency mechanical feature in dose pens and injection devices; it may be less central to novelty than Claim 1’s one-way breakaway coupling. Claim 3-4: Specific pawl wheel geometry for the unidirectional coupling
Business meaning These dependent claims narrow the coupling structure to a ratchet/pawl geometry with specific tooth edge shapes and engagement features. They provide fallback coverage if the “unidirectional coupling” is implemented via the described tooth profile. Claim 5-6: Dose scale drum and helical track/rib thread non-self-locking connection
Business meaning These claims narrow the dose-setting drive train to a helical-track/helical-rib “not self locking” connection between a drum and housing, with axial movement tied to the injection button. Claim 7: Alternative embodiment of the not self locking connection in injection button bore
Business meaning Adds another structural path for the “not self locking thread connection” that drives injection button projection. Claim 8: Another drive train split between driver tube rotation and axial part
Business meaning Again narrows to a specific mechanical arrangement that controls which elements rotate and which translate. 2) Critical analysis: what looks genuinely protectable vs what is vulnerable to prior art and obviousnessA. Protectable core: the one-way coupling with engineered reluctanceThe most distinctive claim element is the unidirectional coupling between nut member and piston rod guide, plus the “initial reluctance” breakaway requirement resisting torque exerted by the dose setting. In mechanical pens and injection devices, common problems include:
Claim 1 addresses this by:
This structure can be argued as more than “use a ratchet,” because it ties the ratchet behavior to the torque produced during the dose-setting step and explicitly requires initial reluctance to exceed a torque threshold. Risk: If prior art shows one-way couplings that inherently resist reverse torque until a pawl climbs a tooth edge (which is common), defendants will argue that the “initial reluctance” is inherent and not a patentable difference, unless the prior art teaches “initial reluctance set large enough to resist torque exerted by the dose setting” in the same functional placement. Enforcement leverage: To preserve breadth, the patentee can point to functional evidence: coupling must not transmit dose-setting torque to piston transport until axial return-driven torque overrides it. To defend validity, the argument must connect the threshold and functional directionality to structure (paws/tooth geometry/springs/friction surfaces) in the specification, because claim language is already functional. B. Claim breadth risk: multiple “not self locking” and “self locking” thread references create ambiguityClaim 1 includes:
If prior art teaches dose mechanisms using threads that are not backdrivable by using geometry (lead angle, friction) that is sometimes described variably as “self-locking” or “not self locking,” claim interpretation may expand or contract depending on how courts handle these mechanical terms. Risk: Defendants can cite prior art where the same effect (no backdriving during one step) is achieved with friction or geometry and is described as “self-locking” in some contexts. This can be used to argue anticipation by equivalence or obviousness by substituting known thread lead/friction configurations. C. Dependent claims 3-4: tooth geometry narrows and may reduce obviousness riskThe pawl wheel with steep front edge and ramp trailing edge is more specific. Many ratchets have asymmetric tooth profiles; the risk is that prior art pawl designs are close enough that these dependent limitations are still met. But dependent claims give a fallback and also a clearer narrative for inventiveness: not just a ratchet, but a ratchet with tooth geometry that delays reverse torque transmission (front edge steepness) and then allows override in one direction. D. Dependent claims 5-8: multiple embodiments increase coverage but also increase invalidity surfaceClaim set includes alternative implementations for:
This is good for infringement capture, but each embodiment invites a separate prior art mapping exercise. The more ways the device can be built, the more likely one path exists in earlier patents. The strategy for a challenger is straightforward: find at least one embodiment in prior art that matches each claim element combination, even if other embodiments differ. 3) Patent landscape: where you should expect the “closest” prior art to sitLandscape segment 1: multi-dose injection pens and mechanical dose setting with threaded conversionThe claim style and mechanical architecture match a well-populated prior art family: devices that use
What to look for in prior art documents
Landscape segment 2: ratchets, unidirectional couplings, and breakaway thresholdsThe unidirectional coupling plus “initial reluctance” places this patent in the sub-landscape of:
What to look for
Landscape segment 3: helical track/dose drum and helical rib dose settingClaims 5-6 align with a dose drum that moves axially with user interaction via a helical track and complementary rib that functions as a non-self-locking thread connection. What to look for
4) Likely claim construction pressure points in US litigationA. “Unidirectional coupling provided between the nut member and the piston rod guide”Accused systems must map rotation between specific elements:
Many commercial syringes may use one-way clutches between different nodes (e.g., coupling between dose dial and lead screw; coupling between button and driver shaft). If the “between” mapping does not align, infringement arguments weaken. B. “Initial reluctance set large enough to resist a torque exerted on the coupling by the dose setting”This is the most litigation-sensitive element. It invites questions of:
If the accused device uses a ratchet pawl without a designed breakaway torque parameter, defendants argue the “initial reluctance” is not met in the claimed sense. The patentee will argue inherent resistance due to pawl angle/tooth geometry constitutes reluctance. C. “Allowed rotation being one by which the piston rod is transported in a distal direction”If an accused device allows one-way rotation in a direction that indirectly advances the piston only after additional steps or via gears, claim mapping may fail if the one-way coupling is not directly tied to distal transport. D. Thread limitations: “not self locking” vs “self locking”Thread classifications depend on lead angle, friction, materials, and lubrication. In litigation, these can become factual debates. 5) Practical assessment: enforceable boundaries and the “thin vs thick” nature of 6,004,297Thick area (best for enforcement)
Thin area (most vulnerable)
Dependent claims as fallback
Key Takeaways
FAQs1) What is the single most distinctive limitation in 6,004,297?The unidirectional coupling between the nut member and piston rod guide with an initial reluctance set to resist torque from the dose-setting step until a threshold is exceeded, enabling only distal piston transport rotation. 2) How does the patent convert dose-setting user input into piston movement?Rotation of a dose setting element drives an injection button outward via a not self-locking thread connection, then returning the button axially converts movement into rotation of piston drive elements so the piston rod advances distally. 3) Do the dependent claims broaden or narrow coverage?They narrow coverage by specifying particular implementations: click coupling (Claim 2), pawl wheel tooth geometry (Claims 3-4), helical dose drum (Claims 5-6), alternative thread in the injection button bore (Claim 7), and driver tube arrangement (Claim 8). 4) Where do infringement arguments typically succeed for this kind of patent?When the accused device matches the full drive-train choreography and especially when it includes a one-way coupling at the nut-guide interface with a breakaway torque effect linked to preventing piston advance during dose setting. 5) What prior art category poses the biggest obviousness threat?Mechanical dose-setting injection devices that use threaded button projection plus ratchet or one-way clutch functions to control piston advance timing and prevent backdriving, particularly those teaching asymmetric ratchet tooth profiles or torque-threshold clutches. References[1] US Patent 6,004,297. More… ↓ |
Details for Patent 6,004,297
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | June 07, 2000 | ⤷ Start Trial | 2019-01-28 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | January 19, 2001 | ⤷ Start Trial | 2019-01-28 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | April 23, 2004 | ⤷ Start Trial | 2019-01-28 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,004,297
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 99714 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9938554 | ⤷ Start Trial |
| United States of America | RE43834 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
